Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-05-2024 | Human Alphaherpesvirus 3 | Case report

Lobaplatin/paclitaxel/sintilimab

Lack of efficacy and acute retinal necrosis

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Wang P, et al. Acute retinal necrosis in a patient with cervical malignant tumor treated with sintilimab: a case report and literature review. [Review] Frontiers in Immunology 15: Jan 2024. Available from: URL: https://dx.doi.org/10.3389/fimmu.2024.1301329 Wang P, et al. Acute retinal necrosis in a patient with cervical malignant tumor treated with sintilimab: a case report and literature review. [Review] Frontiers in Immunology 15: Jan 2024. Available from: URL: https://​dx.​doi.​org/​10.​3389/​fimmu.​2024.​1301329
Metadata
Title
Lobaplatin/paclitaxel/sintilimab
Lack of efficacy and acute retinal necrosis
Publication date
01-05-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-58271-4

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Multiple drugs

Case report

Antineoplastics

Case report

Nivolumab

Case report

Multiple drugs

Case report

Ipilimumab